German Health Minister Pushes Back Hard Against IP Waiver For COVID Vaccines – Predicts Shortages to Become Surplus by 2022 15/07/2021 Elaine Ruth Fletcher Germany’s Health Minister Jens Spahn pushed back hard Thursday against voices calling for a waiver on the intellectual property of COVID-19 treatments and vaccines in a high-profile visit to Geneva. His trip coincided with German Chancellor Angela Merkel’s farewell visit to the United States, including a summit with US President Joe Biden, where protestors chanted […] Continue reading -> WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Hailstorm of Criticism Over EU Denial of COVID ‘Green Pass’ to Recipients of AstraZeneca’s Covishield Vaccine 01/07/2021 Paul Adepoju & Elaine Ruth Fletcher African Union and WHO/African Region officials on Thursday sharply criticized the European Union decision to not grant the Indian version of AstraZeneca’s “Covishield” vaccine, distributed by the global COVAX facility, recognition in the new EU “Digital Green Pass programme” – amidst a growing chorus of global protests over the double standard. In a related statement, […] Continue reading -> Most COVAX Vaccine Recipients Excluded From New EU COVID ‘Green Pass’ – Thanks to Unapproved AstraZeneca Jab 25/06/2021 Paul Adepoju & Elaine Ruth Fletcher The much-trumpeted European Union COVID Digital Green Pass, which launches 1 July and is meant to vastly ease travel to Europe for vaccinated and recovered passengers is being rolled out with one important hitch. Anyone vaccinated with an AstraZeneca vaccine produced by the Serum Institute of India would not be qualified to get the pass […] Continue reading -> WHO, World Trade Organization & World Intellectual Property Organization Map Out Joint Approach to COVID Pandemic 24/06/2021 Elaine Ruth Fletcher In a first-ever tripartite meeting this year, the heads of the World Health Organization, the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO), have agreed to step up their collaboration on tools and resources for fighting the COVID-19 pandemic. The meeting was the first formal tripartite meeting since Ngozi Okonjo-Iweala was […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Hailstorm of Criticism Over EU Denial of COVID ‘Green Pass’ to Recipients of AstraZeneca’s Covishield Vaccine 01/07/2021 Paul Adepoju & Elaine Ruth Fletcher African Union and WHO/African Region officials on Thursday sharply criticized the European Union decision to not grant the Indian version of AstraZeneca’s “Covishield” vaccine, distributed by the global COVAX facility, recognition in the new EU “Digital Green Pass programme” – amidst a growing chorus of global protests over the double standard. In a related statement, […] Continue reading -> Most COVAX Vaccine Recipients Excluded From New EU COVID ‘Green Pass’ – Thanks to Unapproved AstraZeneca Jab 25/06/2021 Paul Adepoju & Elaine Ruth Fletcher The much-trumpeted European Union COVID Digital Green Pass, which launches 1 July and is meant to vastly ease travel to Europe for vaccinated and recovered passengers is being rolled out with one important hitch. Anyone vaccinated with an AstraZeneca vaccine produced by the Serum Institute of India would not be qualified to get the pass […] Continue reading -> WHO, World Trade Organization & World Intellectual Property Organization Map Out Joint Approach to COVID Pandemic 24/06/2021 Elaine Ruth Fletcher In a first-ever tripartite meeting this year, the heads of the World Health Organization, the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO), have agreed to step up their collaboration on tools and resources for fighting the COVID-19 pandemic. The meeting was the first formal tripartite meeting since Ngozi Okonjo-Iweala was […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Hailstorm of Criticism Over EU Denial of COVID ‘Green Pass’ to Recipients of AstraZeneca’s Covishield Vaccine 01/07/2021 Paul Adepoju & Elaine Ruth Fletcher African Union and WHO/African Region officials on Thursday sharply criticized the European Union decision to not grant the Indian version of AstraZeneca’s “Covishield” vaccine, distributed by the global COVAX facility, recognition in the new EU “Digital Green Pass programme” – amidst a growing chorus of global protests over the double standard. In a related statement, […] Continue reading -> Most COVAX Vaccine Recipients Excluded From New EU COVID ‘Green Pass’ – Thanks to Unapproved AstraZeneca Jab 25/06/2021 Paul Adepoju & Elaine Ruth Fletcher The much-trumpeted European Union COVID Digital Green Pass, which launches 1 July and is meant to vastly ease travel to Europe for vaccinated and recovered passengers is being rolled out with one important hitch. Anyone vaccinated with an AstraZeneca vaccine produced by the Serum Institute of India would not be qualified to get the pass […] Continue reading -> WHO, World Trade Organization & World Intellectual Property Organization Map Out Joint Approach to COVID Pandemic 24/06/2021 Elaine Ruth Fletcher In a first-ever tripartite meeting this year, the heads of the World Health Organization, the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO), have agreed to step up their collaboration on tools and resources for fighting the COVID-19 pandemic. The meeting was the first formal tripartite meeting since Ngozi Okonjo-Iweala was […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Hailstorm of Criticism Over EU Denial of COVID ‘Green Pass’ to Recipients of AstraZeneca’s Covishield Vaccine 01/07/2021 Paul Adepoju & Elaine Ruth Fletcher African Union and WHO/African Region officials on Thursday sharply criticized the European Union decision to not grant the Indian version of AstraZeneca’s “Covishield” vaccine, distributed by the global COVAX facility, recognition in the new EU “Digital Green Pass programme” – amidst a growing chorus of global protests over the double standard. In a related statement, […] Continue reading -> Most COVAX Vaccine Recipients Excluded From New EU COVID ‘Green Pass’ – Thanks to Unapproved AstraZeneca Jab 25/06/2021 Paul Adepoju & Elaine Ruth Fletcher The much-trumpeted European Union COVID Digital Green Pass, which launches 1 July and is meant to vastly ease travel to Europe for vaccinated and recovered passengers is being rolled out with one important hitch. Anyone vaccinated with an AstraZeneca vaccine produced by the Serum Institute of India would not be qualified to get the pass […] Continue reading -> WHO, World Trade Organization & World Intellectual Property Organization Map Out Joint Approach to COVID Pandemic 24/06/2021 Elaine Ruth Fletcher In a first-ever tripartite meeting this year, the heads of the World Health Organization, the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO), have agreed to step up their collaboration on tools and resources for fighting the COVID-19 pandemic. The meeting was the first formal tripartite meeting since Ngozi Okonjo-Iweala was […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Hailstorm of Criticism Over EU Denial of COVID ‘Green Pass’ to Recipients of AstraZeneca’s Covishield Vaccine 01/07/2021 Paul Adepoju & Elaine Ruth Fletcher African Union and WHO/African Region officials on Thursday sharply criticized the European Union decision to not grant the Indian version of AstraZeneca’s “Covishield” vaccine, distributed by the global COVAX facility, recognition in the new EU “Digital Green Pass programme” – amidst a growing chorus of global protests over the double standard. In a related statement, […] Continue reading -> Most COVAX Vaccine Recipients Excluded From New EU COVID ‘Green Pass’ – Thanks to Unapproved AstraZeneca Jab 25/06/2021 Paul Adepoju & Elaine Ruth Fletcher The much-trumpeted European Union COVID Digital Green Pass, which launches 1 July and is meant to vastly ease travel to Europe for vaccinated and recovered passengers is being rolled out with one important hitch. Anyone vaccinated with an AstraZeneca vaccine produced by the Serum Institute of India would not be qualified to get the pass […] Continue reading -> WHO, World Trade Organization & World Intellectual Property Organization Map Out Joint Approach to COVID Pandemic 24/06/2021 Elaine Ruth Fletcher In a first-ever tripartite meeting this year, the heads of the World Health Organization, the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO), have agreed to step up their collaboration on tools and resources for fighting the COVID-19 pandemic. The meeting was the first formal tripartite meeting since Ngozi Okonjo-Iweala was […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Most COVAX Vaccine Recipients Excluded From New EU COVID ‘Green Pass’ – Thanks to Unapproved AstraZeneca Jab 25/06/2021 Paul Adepoju & Elaine Ruth Fletcher The much-trumpeted European Union COVID Digital Green Pass, which launches 1 July and is meant to vastly ease travel to Europe for vaccinated and recovered passengers is being rolled out with one important hitch. Anyone vaccinated with an AstraZeneca vaccine produced by the Serum Institute of India would not be qualified to get the pass […] Continue reading -> WHO, World Trade Organization & World Intellectual Property Organization Map Out Joint Approach to COVID Pandemic 24/06/2021 Elaine Ruth Fletcher In a first-ever tripartite meeting this year, the heads of the World Health Organization, the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO), have agreed to step up their collaboration on tools and resources for fighting the COVID-19 pandemic. The meeting was the first formal tripartite meeting since Ngozi Okonjo-Iweala was […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO, World Trade Organization & World Intellectual Property Organization Map Out Joint Approach to COVID Pandemic 24/06/2021 Elaine Ruth Fletcher In a first-ever tripartite meeting this year, the heads of the World Health Organization, the World Trade Organization (WTO) and the World Intellectual Property Organization (WIPO), have agreed to step up their collaboration on tools and resources for fighting the COVID-19 pandemic. The meeting was the first formal tripartite meeting since Ngozi Okonjo-Iweala was […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts